Stock TCBP TC BIOPHARM (HOLDINGS) PLC
Add to a list
To use this feature you must be a member
Log inSign up

Company TC Biopharm (Holdings) Plc

Equities

TCBP

US87807D4007

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
1.53 USD -2.55% Intraday chart for TC Biopharm (Holdings) Plc +3.45% -51.74%
Apr. 25 European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading MT
Apr. 23 European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading MT

Business Summary

TC BioPharm Limited is a clinical-stage biopharmaceutical company. The Company is engaged in developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma-delta T cell therapies for the treatment of infectious disease. The Company's platform technology allows the Company to design specific therapies to treat a range of cancers and infectious diseases with off-the-shelf allogeneic gamma-delta T cell (GDT) products. The Company’s pipeline includes OmnImmune and CAR-T programs. OmnImmune is an unmodified allogeneic gamma-delta T cell product being used for the treatment of acute myeloid leukemia (AML). The Company has completed a Phase II clinical trial. Its CAR-T programs include in-house and partner programs at the pre-clinical-stage focused on developing CAR modified allogeneic gamma delta T-cell products targeting solid and hematological indications.

Number of employees: 41

Managers

Managers TitleAgeSince
Michael Leek FOU
 Founder 64 12-12-31
Bryan Kobel CEO
 Chief Executive Officer 44 21-05-31
Martin Thorp DFI
 Director of Finance/CFO 72 14-12-31
Bree Harlin CTO
 Chief Tech/Sci/R&D Officer - -

Members of the board

Members of the board TitleAgeSince
Mark Bonyhadi BRD
 Director/Board Member 70 22-02-21
Martin Thorp DFI
 Director of Finance/CFO 72 14-12-31
Arlene Morris CHM
 Chairman 72 22-02-21
Michael Leek FOU
 Founder 64 12-12-31
Edward Niemczyk BRD
 Director/Board Member 44 22-02-21
Anthony Culverwell BRD
 Director/Board Member 68 22-02-21
Bryan Kobel CEO
 Chief Executive Officer 44 21-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,479,958 2,188,811 ( 88.26 %) 0 74.24 %
Stock B 20 468,179 0 0

Shareholders

NameEquities%Valuation
Armistice Capital LLC
3.050 %
74,000 3.050 % 96 940 $
Tower Research Capital LLC
0.1142 %
2,770 0.1142 % 3 629 $
Steward Financial Group LLC
0.004121 %
100 0.004121 % 131 $
J.P. Morgan SE
0.003668 %
89 0.003668 % 117 $
Wells Fargo Clearing Services LLC
0.002061 %
50 0.002061 % 66 $
NameEquities%Valuation
Armistice Capital LLC
-
1,882,352 - 37 647 $
Kepos Capital LP
-
470,588 - 9 412 $
Nantahala Capital Management LLC
-
235,294 - 4 706 $
Virtu Financial LLC
-
29,803 - 596 $
Altium Capital Management LP
-
18,823 - 376 $
UBS Securities LLC
-
13,609 - 272 $
G1 Execution Services LLC
-
11,406 - 228 $
BofA Securities, Inc.
-
529 - 11 $
NameEquities%Valuation
Renaissance Capital Partners Ltd.
14.40 %
136,834 14.40 % 50 355 $
MEDINET CO., LTD.
7.737 %
73,500 7.737 % 27 048 $
Mark Edward Randall
1.048 %
9,952 1.048 % 3 662 $
Bryan Kobel
0.2212 %
2,101 0.2212 % 773 $
Ken Randall
0.2114 %
2,008 0.2114 % 739 $
Mark Bonyhadi
0.000000 %
0 0.000000 % - $
Anthony Culverwell
0.000000 %
0 0.000000 % - $
Edward Niemczyk
0.000000 %
0 0.000000 % - $
Arlene Morris
0.000000 %
0 0.000000 % - $
Martin Thorp
0.000000 %
0 0.000000 % - $

Company contact information

TC Biopharm (Holdings) Plc

Maxim Park 1 2 Parklands Way

ML1 4WR, Motherwell

+44 14 1433 7557

http://www.tcbiopharm.com
address TC Biopharm (Holdings) Plc(TCBP)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
TC BIOPHARM (HOLDINGS) PLC Stock TC Biopharm (Holdings) Plc
-51.74% 4.89M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. TCBP Stock
  4. Company TC Biopharm (Holdings) Plc